ArticleThe International journal of angiology : official publication of the International College of Angiology, Inc2025
Unusual Incidence of Acute Type A Aortic Dissection during COVID-19.
Article in The International journal of angiology : official publication of the International College of Angiology, Inc, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Seasonal variations have been identified in the incidence of Stanford acute type A aortic dissection (ATAAD), and these have been only further impacted by the recent COVID-19 pandemic. We sought to examine the incidence and presentation of ATAAD during the initial height of the COVID-19 pandemic during the year 2020 and compare this with our pre-pandemic experience. A retrospective review was undertaken of all consecutive patients who had ATAAD repair between January 2014 and December 2020. The incidence and pattern of presentation during 2020 was compared with that of the prior 6 years. A total of 339 patients underwent ATAAD during the study period, 301 (88.8%) from 2014 to 2019 (pre-COVID-19) and 38 (11.2%) during 2020 (coincident with COVID-19). We found a marked decrease in the incidence of ATAAD during COVID-19 as compared to the aggregate of our prior experience. During the height of the COVID-19 pandemic, we witnessed significantly fewer patients presenting with ATAAD, presumably due to a combination of "lockdown" restrictions, perhaps coupled with reduced influenza activity in the population. This was followed by an unusual rebound in the incidence of ATAAD, a phenomenon not previously noted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.